SARS-CoV-2 Early Screening at the Point of Entry: Travelers From Bangladesh to Italy-July 2020.

COVID-19 SARS-CoV-2 early detection at point of entry molecular epidemiology mutations next generation genome sequencing phylogenetic analysis

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2021
Historique:
received: 03 11 2020
accepted: 18 01 2021
entrez: 26 2 2021
pubmed: 27 2 2021
medline: 27 2 2021
Statut: epublish

Résumé

We report phylogenetic and mutational analysis by NGS of six SARS-CoV-2 strains from patients flying from Bangladesh to Italy (July 2020). Data suggest that no further circulation of such imported strains occurred in Italy, stating the efficacy of early screening at the point of entry and supporting the importance of molecular epidemiology in monitoring the efficacy of control measures.

Identifiants

pubmed: 33633786
doi: 10.3389/fgene.2021.625607
pmc: PMC7900618
doi:

Types de publication

Journal Article

Langues

eng

Pagination

625607

Informations de copyright

Copyright © 2021 Rueca, Di Caro, Gruber, Messina, Giombini, Valli, Lalle, Lanini, Vairo, Capobianchi and Bartolini.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Bioinformatics. 2012 Dec 1;28(23):3150-2
pubmed: 23060610
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Transbound Emerg Dis. 2020 Jul 23;:
pubmed: 32701194
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
PLoS One. 2021 Jan 20;16(1):e0245584
pubmed: 33471859
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794443
Nat Microbiol. 2021 Mar;6(3):415
pubmed: 33514928

Auteurs

Martina Rueca (M)

National Institute for Infectious Diseases, INMI (Istituto Nazionale per le Malattie Infettive), "Lazzaro Spallanzani" IRCCS (Istituto di ricovero e Cura a Carattere Scientifico), Rome, Italy.

Antonino Di Caro (A)

National Institute for Infectious Diseases, INMI (Istituto Nazionale per le Malattie Infettive), "Lazzaro Spallanzani" IRCCS (Istituto di ricovero e Cura a Carattere Scientifico), Rome, Italy.

Cesare Ernesto Maria Gruber (CEM)

National Institute for Infectious Diseases, INMI (Istituto Nazionale per le Malattie Infettive), "Lazzaro Spallanzani" IRCCS (Istituto di ricovero e Cura a Carattere Scientifico), Rome, Italy.

Francesco Messina (F)

National Institute for Infectious Diseases, INMI (Istituto Nazionale per le Malattie Infettive), "Lazzaro Spallanzani" IRCCS (Istituto di ricovero e Cura a Carattere Scientifico), Rome, Italy.

Emanuela Giombini (E)

National Institute for Infectious Diseases, INMI (Istituto Nazionale per le Malattie Infettive), "Lazzaro Spallanzani" IRCCS (Istituto di ricovero e Cura a Carattere Scientifico), Rome, Italy.

Maria Beatrice Valli (MB)

National Institute for Infectious Diseases, INMI (Istituto Nazionale per le Malattie Infettive), "Lazzaro Spallanzani" IRCCS (Istituto di ricovero e Cura a Carattere Scientifico), Rome, Italy.

Eleonora Lalle (E)

National Institute for Infectious Diseases, INMI (Istituto Nazionale per le Malattie Infettive), "Lazzaro Spallanzani" IRCCS (Istituto di ricovero e Cura a Carattere Scientifico), Rome, Italy.

Simone Lanini (S)

National Institute for Infectious Diseases, INMI (Istituto Nazionale per le Malattie Infettive), "Lazzaro Spallanzani" IRCCS (Istituto di ricovero e Cura a Carattere Scientifico), Rome, Italy.

Francesco Vairo (F)

National Institute for Infectious Diseases, INMI (Istituto Nazionale per le Malattie Infettive), "Lazzaro Spallanzani" IRCCS (Istituto di ricovero e Cura a Carattere Scientifico), Rome, Italy.

Maria Rosaria Capobianchi (MR)

National Institute for Infectious Diseases, INMI (Istituto Nazionale per le Malattie Infettive), "Lazzaro Spallanzani" IRCCS (Istituto di ricovero e Cura a Carattere Scientifico), Rome, Italy.

Barbara Bartolini (B)

National Institute for Infectious Diseases, INMI (Istituto Nazionale per le Malattie Infettive), "Lazzaro Spallanzani" IRCCS (Istituto di ricovero e Cura a Carattere Scientifico), Rome, Italy.

Classifications MeSH